Ensign Peak Advisors
SPPI

Ensign Peak Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Ensign Peak Advisors’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-98,500
Closed -$359K – 1702
2019
Q4 		$359K Buy
+98,500
New +$796K ﹤0.01% 1561

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ensign Peak Advisors's SPPI Position: Q1 2020 in Review

Ensign Peak Advisors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2020, closing a stake of 98,500 shares — an estimated $359K sold.

Ensign Peak Advisors first reported a position in SPPI in Q4 2019 and held it in 1 quarter. The position peaked at $359K in Q4 2019. 156 funds tracked by Wall St. Rank hold SPPI as of Q1 2020.

  • Ensign Peak Advisors reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2020 after selling out during the quarter.
  • Ensign Peak Advisors sold 98,500 Spectrum Pharmaceuticals Inc shares in Q1 2020, an estimated $359K.
  • Ensign Peak Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q4 2019 and held it in 1 quarter.
  • Ensign Peak Advisors's Spectrum Pharmaceuticals Inc position peaked at $359K in Q4 2019.
  • 156 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2020.

Based on Ensign Peak Advisors's 13F filing for Q1 2020, filed 11 May 2020.